Carl Anthony Evans Cns Pharmaceuticals, Inc. (CNSP) insider trading activity

CNSP Quotes by TradingView

Carl Anthony Evans is Director of CNS Pharmaceuticals, Inc.. Currently has a direct ownership of 33,458 shares of CNSP, which is worth approximately $3,680. The most recent transaction as insider was on Feb 01, 2024, when has been sold 33,333 shares (Common Stock) at a price of $0.3 per share, resulting in proceeds of $9,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.5K
0% 3M change
792.21% 12M change
Total Value Held $3,680

Carl Anthony Evans Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
BUY
Open market or private purchase
$9,999 $0.3 p/Share
33,333 Added 49.91%
33,458 Common Stock
Mar 08 2022
BUY
Grant, award, or other acquisition
$1,013 $0.27 p/Share
3,750 Added 50.0%
3,750 Common Stock
CAE

Carl Anthony Evans

Director
Houston, TX

Track Institutional and Insider Activities on CNSP

Follow CNS Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNSP shares.

Notify only if

Insider Trading

Get notified when an Cns Pharmaceuticals, Inc. insider buys or sells CNSP shares.

Notify only if

News

Receive news related to CNS Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CNSP